Fujifilm Holdings Corp
TSE:4901

Watchlist Manager
Fujifilm Holdings Corp Logo
Fujifilm Holdings Corp
TSE:4901
Watchlist
Price: 3 017 JPY -0.23% Market Closed
Market Cap: 3.6T JPY

Fujifilm Holdings Corp
Investor Relations

Fujifilm Holdings Corp. is a compelling narrative of transformation and resilience in the business world. Originally a titan in the photographic film industry, the company faced an existential threat when the world pivoted to digital photography. Instead of succumbing to obsolescence, Fujifilm embarked on a remarkable diversification journey. The company leveraged its core competencies in chemistry and materials science to expand into various sectors, including healthcare, graphic systems, optical devices, and advanced materials. Fujifilm's aggressive shift into these sectors is underpinned by its commitment to innovation, with substantial investments in research and development driving new product and solution offerings.

Today, Fujifilm's operations are a mix of these diverse enterprises. In healthcare, its offerings range from medical imaging and pharmaceuticals to regenerative medicine, generating significant revenue streams. The document solutions division caters to businesses worldwide with printers and copiers, offering both product sales and recurring service contracts. In its original imaging solutions business, which now encompasses digital cameras and instant photo systems like Instax, Fujifilm continues to capitalize on both innovation and nostalgia, maintaining strong profitability. Through strategic acquisitions and partnerships, Fujifilm enhances its market position and reinforces its footprint across these varied industries, turning past challenges into a continuous narrative of growth and adaptation.

Show more
Loading

Earnings Calls

2019 Q3
Feb 7, 2019
Show Transcript
Previous
Next
Fujifilm Shows Resilience with Stable Revenue and Increased Operating Income
2019 Q3
Feb 7, 2019

Fujifilm Holdings reported stable revenue of JPY 1,799.8 billion in Q3, matching last year's figures while operating income soared 28.6% to JPY 158.3 billion, driven by strong performances in medical systems and electronic materials. Notably, net income decreased 18.8%, impacted by prior stock valuation gains and new accounting standards. The Healthcare & Material Solutions segment grew 4.2% to JPY 758.9 billion, with operating income rising 17%. Fujifilm's buyback plan is progressing, totaling JPY 75.4 billion, and the annual dividend is expected to increase to JPY 80 per share, marking the ninth consecutive annual increase.

Management

Mr. Kenji Sukeno
Executive Chairman of The Board
No Bio Available
Mr. Teiichi Goto
President, CEO & Director
No Bio Available
Mr. Masayuki Higuchi
Corporate VP, GM of Corporate Planning Division, Accounting and Finance Div, CFO & Director
No Bio Available
Ms. Chisato Yoshizawa
Corporate VP, GM of Corp Communications and ESG Division-Global Audit Dep, Brand Mgmt & Director
No Bio Available
Atsushi Sakurai
Corporate VP & GM of Legal Division
No Bio Available
Yasushi Zama
Corporate VP and GM of Human Resources Division & Corporate General Administration Division
No Bio Available
Mr. Shigetaka Komori
Executive Advisor
No Bio Available
Kazuhisa Horikiri
Corporate VP & GM of Design Strategy Office
No Bio Available
Seigo Sugimoto
Corporate VP, Chief Digital Officer & GM of ICT Strategy Office
No Bio Available
Shuzo Takada
Corporate VP & GM of Government Relations Div
No Bio Available

Contacts

Address
TOKYO-TO
Minato-ku
9-7-3, Akasaka
Contacts